Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tenaya Therapeutics, Inc. - Common Stock
(NQ:
TNYA
)
0.8929
+0.0342 (+3.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tenaya Therapeutics, Inc. - Common Stock
Rapid Dose (CSE: DOSE) (OTCQB: RDTCF) Global Patent for QuickStrip™ in the $38B Smoke-Free Nicotine Market – Watch TNYA, UOKA, SGN, MMCP Today!
March 09, 2026
Via
AB Newswire
Topics
Intellectual Property
Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-In-Class Cardiovascular Therapeutics
June 16, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor at European Society of Cardiology Heart Failure 2022 Conference
May 20, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting
May 03, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Present Preclinical Data on TN-401 PKP2 Gene Therapy Program at Heart Rhythm 2022
April 28, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
March 24, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Updates
March 23, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
January 31, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics Provides 2022 Business Updates
January 10, 2022
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics Appoints Karah Parschauer, J.D., to Its Board of Directors and Joanna Auch as Senior Vice President of People and Culture
December 22, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics Announces the Addition of Dr. June Lee to its Board of Directors
November 22, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
November 19, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates
November 10, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress
October 12, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
September 30, 2021
From
Tenaya Therapeutics
Via
Business Wire
Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
September 08, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics to Present at Morgan Stanley 19th Annual Global Healthcare Conference
August 31, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
August 03, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Tenaya Therapeutics Announces Pricing of Upsized Initial Public Offering
July 29, 2021
From
Tenaya Therapeutics, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
